Va Neuroscience Initiative Adds Sentara
Thursday, May 11, 2017
The Virginia Biosciences Health Research Corporation-“the Catalyst”, has established the Virginia Neuroscience Initiative (VNI) and recognized Sentara Healthcare as one of its five core medical group partners.
The VNI is an innovative, statewide collaborative that will unite experienced neuroscientists, medical providers and industry partners who share a common mission to advance research on treatments for various neurological disorders. It will be both an incubator and an accelerator for clinical and translational research in neurological disorders. Further, it will provide economic opportunities for the Commonwealth of Virginia through expanded government, private equity and philanthropy funding, as well as new company formation and corporate sponsored research.
“Establishing the VNI and including Sentara as one of its key medical groups is an important step in enabling greater research collaboration and best practice cross pollination in the neurosciences field,” said Alexander Grunsfeld, MD, chief of neurology, Sentara Medical Group and medical director of neurosciences, Sentara Healthcare.
Sentara joins other medical groups including Carilion Clinic, Inova Health System, UVA Health System and VCU Health, as well as seven academic institutions including Eastern Virginia Medical School, George Mason University, Old Dominion University, University of Virginia, Virginia Commonwealth University, Virginia Tech and William & Mary, in the collaborative.
“From increased access to cutting-edge technology and tools to more robust research capabilities, the benefits of the collaborative are significant,” Dr. Grunsfeld said. “Working more closely with the core partners will empower us all to drive innovative breakthroughs that will benefit patients across the state and beyond.”
One of the VNI’s first projects is the development of the VNI Neuroscience Registry which is designed to facilitate collaboration among scientists, physicians, clinical researchers and research organizations in the fields of neuroscience and psychiatry.
The registry is open to anyone that may have expertise that could contribute to neurosciences advancements and Dr. Grunsfeld encourages people across the field to register.
“The neuroscience registry is an excellent tool for facilitating potential research partnerships based on similar interests or projects, as well as background and skill sets,” said Dr. Grunsfeld. “I’m excited for Sentara to be a VNI core partner and look forward to the important achievements the collaborative will foster.”